Manage Your OSA with Zepbound
The first and only prescription medicine for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity
What is Zepbound?
Zepbound is an injectable prescription medicine that may help adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity to improve their OSA. Zepbound should be used with a reduced-calorie diet and increased physical activity.
- Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines.
- It is not known if Zepbound is safe and effective for use in children.
Improve Sleep Apnea
Lose Weight
Prescribed by a Pulmonologist
Ongoing and Personal Medication Management
How To Get Started
1.
Submit a request for a consultation
2.
Schedule an appointment with a specialist
3.
While waiting for an appointment, become familiar with Zepbound treatment and side-effects.
4.
Experience your personal ongoing treatment and care
Additional results:
Zepbound helps improve the effect of OSA on blood-oxygen levels during sleep*§
When breathing is disrupted during sleep, blood oxygen levels may decrease. With Zepbound (10 mg or 15 mg), the level and the time of reduced blood oxygen while sleeping (called hypoxic burden) improved.§
*Along with diet and exercise.
§In a 52-week study, adults taking Zepbound (10 mg or 15 mg) had a starting average hypoxic burden of 153.6% min/h that was reduced by 95.2% min/h (vs a starting average of 137.8% min/h that was reduced by 25.1% min/h with placebo). In another 52-week study of adults on PAP therapy, those taking Zepbound (10 mg or 15 mg) had a starting average hypoxic burden of 132.2% min/h that was reduced by 103.0% min/hr (vs a starting average of 142.1% min/h that was reduced by 41.7% min/hr with placebo).
People taking Zepbound for OSA also lost significant weight*
People taking Zepbound (10 mg or 15 mg) lost about 50 lbs (20%).||
